The invention relates to the technical field of antibiotic enzymes, and provides
a peptide fusion antibiotic
enzyme, the
peptide fusion antibiotic
enzyme comprises a catalytic domain LysS23, a
cell-penetrating
peptide and a connecting
peptide, the catalytic domain LysS23 comprises an
amino acid sequence represented by SEQ ID NO: 1, the
cell-penetrating peptide comprises an
amino acid sequence represented by SEQ ID NO: 2, and the connecting peptide comprises an
amino acid sequence represented by SEQ ID NO: 3. Or an amino acid sequence which is obtained by substitution / deletion / addition of one or more amino acid residues on the amino acid sequence as shown in SEQ ID NO.1 and has more than 98% of identity is obtained by substitution / deletion / addition of one or more amino acid residues on the amino acid sequence as shown in SEQ ID NO.1. The catalytic domain LysS23 in the peptide fusion antibiotic
enzyme has
peptidoglycan lysis activity, the
cell-penetrating peptide exerts a cell-penetrating function and has an outer membrane destruction effect, the cell-penetrating peptide acts on an
extracellular membrane and helps the catalytic domain LysS23 to smoothly reach the
peptidoglycan position of a
cell wall so as to quickly exert the
lysis effect, and the connecting peptide maintains the integrity of the structures and functions of the cell-penetrating peptide and the catalytic domain. Meanwhile, the
antibacterial activity of the peptide fusion antibiotic enzyme is ensured. The peptide fusion antibiotic enzyme provided by the invention can directly act on common
gram-negative
bacteria without depending on the addition of a chemical outer membrane penetrant, exerts a good
antibacterial effect, and has a very good application value.